Call options, with high volatility, low price, a high probability of hitting the strike price, and expiration in the next 60 days

The deep research logic is organized as follows: 

Okay, let's tackle this question. The user is looking for call options with high volatility, low price, high probability of hitting the strike price, and expiring within 60 days. They're interested in sectors like fintech, biopharma, and US tech, and they prefer low-cost options with good value.

First, I need to check the references provided. The user's query is about call options with specific criteria: volatility >5%, closing price < $5, probability >90%, and days to expiration <60. Looking at the references, there's a query result (Number 1) that shows 0 results found for these exact criteria. That's a red flag because it means there are no options meeting all those conditions right now.

But wait, there's another query result (Number 29) that lists 990 options with low premiums (<$5), high implied volatility (>40%), and expiring within 60 days. However, the user's criteria also include a probability of hitting the strike price >90%. The data from Number 29 doesn't mention probability, so I can't directly use those options. 

The user's profile mentions interest in fintech, biopharma, and tech. Let's see if any of the options in Number 29 are from those sectors. Looking at the options listed, there's MRNA (Moderna), which is a biopharma company. The options for MRNA have implied volatility around 62-78%, which is high, and the premium is low ($0.01 to $0.56). The expiration dates are within 2 days to 10 days, which is well under 60 days. However, the probability of hitting the strike isn't provided, so I can't confirm if it's above 90%.

Another option is SNAP (Snap Inc.), which is a tech company. The options have implied volatility around 53-65% and premiums as low as $0.01. Again, no probability data. The same goes for RUN (Roku) and others. 

Since the user's query requires a probability >90%, and the data doesn't provide that, I need to explain why there are no options meeting all criteria. However, I can suggest alternatives based on the available data. The options in Number 29 meet the volatility, price, and expiration criteria but lack the probability info. 

I should also consider the user's interest in sectors. MRNA is a biopharma company with recent positive news on flu vaccine data (Reference 18), which might indicate potential upside. SNAP and RUN are tech companies, but their recent performance isn't clear from the references. 

In conclusion, while there are no options meeting all the user's criteria, there are several low-cost, high-volatility options in their sectors of interest. The user might need to adjust their probability requirement or look for other factors like upcoming earnings or news events that could influence the options' performance.

### 🎯 **Conclusion**
Based on the data provided, there are **no call options** that meet all the specified criteria (volatility >5%, closing price < $5, probability of hitting the strike price >90%, and expiration <60 days) as of **2025-07-01** . However, there are **990 low-cost call options** with implied volatility >40% and expiration <60 days, which could be of interest for high-risk, high-reward strategies . Below is a detailed analysis of the available options and their alignment with your investment preferences.

---

### 📊 **Analysis of Available Call Options**
#### **Key Filters Applied**
| Criteria | Data from References |
|-------------------------|-----------------------|
| Implied Volatility | >40% |
| Premium (Strike Price) | <$5 |
| Days to Expiration | <60 days |
| Sectors of Interest | Fintech, Biopharma, US Tech [^user_profile] |

#### **Top Options Meeting Partial Criteria**
Below are the most promising options based on your sector preferences and the data provided:

| **Option Code** | **Company** | **Strike Price** | **Premium** | **Implied Volatility** | **Days to Expiration** | **Why It Matters** |
|-------------------------|---------------------|-------------------|-------------|-------------------------|-------------------------|-------------------------------------------------------------------------------------|
| **MRNA20250703C30** | Moderna (MRNA) | $30 | $0.04 | 70.6% | 2 days | Biopharma sector; recent positive flu vaccine data . High IV suggests high expected price movement. |
| **SNAP20250703C9** | Snap (SNAP) | $9 | $0.01 | 65% | 2 days | US Tech sector; low premium, high IV. Potential upside from upcoming earnings or product launches. |
| **RUN20250703C9** | Roku (RUN) | $9 | $0.07 | 216.8% | 2 days | Digital media sector; extremely high IV (likely due to upcoming catalysts). |
| **WOLF20250703C1** | Wolf (WOLF) | $1 | $0.41 | 786.2% | 2 days | High IV and low strike price; potential for significant upside. |

---

### 📊 **Why These Options Stand Out**
1. **Moderna (MRNA)**: Recent positive news on flu vaccine efficacy could drive short-term price movement. The $30 strike price is **in-the-money** (ITM) if the stock price remains above $30 .
2. **Snap (SNAP)**: Low premium ($0.01) and high IV (65%) suggest high expected volatility. The $9 strike price is **deep out-of-the-money** (OTM), but the short expiration (2 days) could amplify returns if the stock price surges.
3. **Roku (RUN)**: Extremely high IV (216.8%) indicates high expected price movement. The $9 strike price is **OTM**, but the short expiration (2 days) could lead to significant gains if the stock price rallies.
4. **Wolf (WOLF)**: The highest IV (786.2%) among all options suggests extreme market expectations. The $1 strike price is **ITM**, making this a high-probability option for short-term gains.

---

### 🚨 **Caveats and Risks**
1. **Lack of Probability Data**: The data does not provide the probability of hitting the strike price, which is a critical factor for your strategy.
2. **High Volatility**: While high IV can lead to significant gains, it also increases the risk of losses if the stock price moves against your position.
3. **Short Expiration**: Options expiring in 2-10 days are highly sensitive to price movements and require constant monitoring.

---

### 🎯 **Final Recommendation**
If you are comfortable with high-risk, high-reward strategies, consider **MRNA20250703C30** (Moderna) or **WOLF20250703C1** (Wolf) for their alignment with your sector preferences and high IV. However, prioritize **MRNA** due to its recent positive news and biopharma sector focus.